Cargando…

SUN-236 Testosterone and Glucagon-Like Peptide-1 Agonists for Type 2 Diabetes Mellitus: A Prospective Cohort Study

Weight loss from diet, exercise, and bariatric surgery consistently increases serum testosterone in men with functional hypogonadism. There is little information about how medications that result in weight loss affect testosterone. Many men with Type 2 Diabetes Mellitus (T2DM) are now taking Glucago...

Descripción completa

Detalles Bibliográficos
Autor principal:	Graybill, Sky
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553149/ http://dx.doi.org/10.1210/js.2019-SUN-236

Ejemplares similares

SUN-233 Testosterone Ordering Processes in a Military Health System
por: Beauvais, Alexis, et al.
Publicado: (2019)

SUN-LB044 Effects of Glucagon-Like Peptide-1 (GLP-1) on the Hypothalamic-Pituitary-Gonadal Axis in Healthy Men
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2019)

SUN-234 Effect of Testosterone Undecanoate on Metabolic Syndrome Parameters in a Cohort of Hypogonadism
por: Yadav, Subhash Chandra, et al.
Publicado: (2019)

SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis
por: Yang, Almira, et al.
Publicado: (2019)

SUN-217 Alternate Pathways of Testosterone Action in Testis
por: Talapatra, Arpita
Publicado: (2019)

SUN-206 Acute Cardiovascular Complications FromTestosterone Therapy
por: Shakir, Mohamed, et al.
Publicado: (2019)

SUN-229 The Role of Testosterone in Spermatogenesis: Lessons from Proteome Profiling of Human Spermatozoa in Testosterone Deficiency
por: Grande, Giuseppe, et al.
Publicado: (2019)

SUN-044 Gonadotropin Releasing Hormone (GnRH) Agonist Therapy Induces a Sustained Reduction in Plasma Testosterone Levels and Is Well Tolerated in Transwomen Veterans
por: Gondin, Lyan, et al.
Publicado: (2020)

SUN-220 The Effect of Testosterone Nasal Gel on Reproductive Hormones and Semen Parameters
por: Masterson, Thomas, et al.
Publicado: (2019)

SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

SUN-029 Diabetes Mellitus Associated with Klinefelter Syndrome
por: Sarria, Carolina, et al.
Publicado: (2020)

SUN-232 Testosterone Deficiency among Thai Men with Type 2 Diabetes: Prevalence and Associated Factors
por: Kittipinyovath, Pakanit, et al.
Publicado: (2019)

SUN-227 Monitoring Testosterone (T) Levels in Men Receiving Oral Testosterone Undecanoate (TU): Challenges Due to Post-Collection Conversion of TU-to-T and a Path Forward
por: Swerdloff, Ronald, et al.
Publicado: (2019)

SUN-222 Testosterone Treatment in Men with Classical vs. Functional Hypogonadism: A 9-Year Registry
por: Zitzmann, Michael, et al.
Publicado: (2019)

SUN-195 Falsely Elevated Testosterone Levels: Role of LC-MS/MS in Reducing Unnecessary Testing
por: Huq, Sabrina, et al.
Publicado: (2019)

SUN-LB040 Associations of Testosterone and Sex Hormone Binding Globulin with the Risk of Cardiovascular Disease and Type 2 Diabetes in Men
por: Wittert, Gary, et al.
Publicado: (2019)

SUN-224 Testosterone Reduces Expression of Inflammatory Targets in Human Macrophages as a Potential Mechanism to Improve Atherosclerosis
por: Bateman, Lauren, et al.
Publicado: (2019)

LBMON236 Investigating The Effect Of Social Vulnerability Index On Fibroid Recurrence And Metabolic Dysfunction
por: Allen, Antoinette, et al.
Publicado: (2022)

SUN-017 Developmental Programming: Prenatal Testosterone Treatment Induced Metabolic Defects May Involve Premature Cellular Senescence
por: Puttabyatappa, Muraly, et al.
Publicado: (2020)

SUN-015 Developmental Programming: Depot-Specific Inflammatory State and Distribution of Thermogenic Adipocytes Programmed by Gestational Testosterone Excess
por: Ciarelli, Joseph Norman, et al.
Publicado: (2020)

SUN-223 Impact of Testosterone Replacement Therapy (TRT) on Prostate Specific Antigen (PSA) in Patients with Clinical Evidence of Prostate Hyperplasia
por: Subramaniam, Shreya, et al.
Publicado: (2019)

SUN-LB043 Phase 2 Randomized Study of the Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients with Hypogonadism
por: Tishova, Yuliya, et al.
Publicado: (2019)

SUN-221 Effects of Liraglutide on Obesity-Associated Functional Hypogonadism in Men: A Randomized, Testosterone Replacement Treatment-Controlled Study
por: Jensterle Sever, Mojca, et al.
Publicado: (2019)

SUN-237 Higher Doses of Testosterone Gel Required in Hypogonadal Men with Obesity to Achieve Therapeutic Replacement - Advice on Dose Titration
por: Mumdzic, Enis, et al.
Publicado: (2019)

SUN-049 Male Pattern Baldness and Waist-Hip Ratio as Markers of Arterial Stiffness in Transgender Men Undergoing Long-Term Testosterone Therapy
por: Alvares, Leonardo Azevedo Mobilia, et al.
Publicado: (2020)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

SUN-226 Improvements In Quality Of Life In Men With Hypogonadism Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): Experience From 6,500 Patient-years Ina Registry Study Ina Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

SUN-LB039 Novel Use of Thromboelastography (TEG) to Investigate the Prothrombotic Effects of Testosterone Replacement Therapy (TRT) for Androgen Deficiency (AD) Established with Diagnostic Rigor (DR)
por: Subramaniam, Shreya, et al.
Publicado: (2019)

SUN-238 Clinical Presentation, Management And Follow-up Of 83 Leydig Cell Tumors Of The Testis: A Prospective Case-cohort Study.
por: Isidori, Andrea, et al.
Publicado: (2019)

It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
por: Oberle, Megan M., et al.
Publicado: (2019)

SUN-053 Evaluation of a 52-Year-Old Transgender Man During the First Year of Testosterone Therapy - Biochemical Changes, Body Composition and Cardiovascular Aspects at the Ergometric Test: A Case Report
por: Alvares, Leonardo Azevedo Mobilia, et al.
Publicado: (2020)

THU645 Comparison Of LC-MS/MS Testosterone Assays Towards Standardization Of Lower Testosterone Ranges
por: Cree, Melanie G, et al.
Publicado: (2023)

SUN-025 Obesity Severity and Polycystic Ovary Syndrome in an Ethnically Diverse Cohort of Adolescent Girls
por: Khil, Jaclyn, et al.
Publicado: (2020)

SUN-LB042 The Novel Androgen 11β-Methyl-19-Nortestosterone Dodecylcarbonate (11β-MNTDC) Effectively Suppresses Gonadotropins and Testosterone in Healthy Men: A Potential Oral Male Hormonal Contraceptive
por: Yuen, Fiona, et al.
Publicado: (2019)

SAT-045 Free Testosterone and Cardiometabolic Parameters in Adult Men - Comparison of Algorithms for Calculation of Serum Free Testosterone
por: Holmboe, Stine Agergaard, et al.
Publicado: (2020)

OR25-4 Active Testosterone Treatment Impairs In Vitro Fertilization (IVF) Outcomes in a Female Mouse Model for Gender-Affirming Testosterone with Improvement in Outcomes Following Cessation of Testosterone Treatment
por: Moravek, Molly B, et al.
Publicado: (2022)

SAT-047 Adoption of an Age Adjusted Testosterone Reference Range Reduces Referrals to Endocrine Clinic and New Prescriptions of Testosterone
por: Dewdney, Charlotte, et al.
Publicado: (2020)

SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment
por: DelConte, Anthony, et al.
Publicado: (2020)

Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021)

SUN-196 Generation of Potent Inhibin Analogues
por: Goney, Monica, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_evf6u8fn0u6koo744dhqeoeio9